YANCOPOULOS GEORGE sold REGN
May 16, 2024 · Form 4 insider transaction
YANCOPOULOS GEORGE sold 3,213 shares of Regeneron Pharmaceuticals, Inc. at $968.44 per share, a transaction worth $3.11M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
Disposition/acquisition made pursuant to plans intended to comply with Rule 10b5-1(c) adopted on February 14, 2024.; Represents volume-weighted average price of sales of 3,213 shares of Company stock on May 16, 2024 at prices ranging from $968.04 to $968.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.